Bliss GVS Pharma
add_icon

Bliss GVS Pharma

237.28
+3.10
(1.32%)
Market Cap
2,510.16 Cr
PE Ratio
21.67
Volume
15,75,701.00
Day High - Low
238.70 - 229.02
52W High-Low
243.90 - 108.12
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,510.16 Cr
EPS
8.02
PE Ratio
21.67
PB Ratio
2.19
Book Value
107.04
EBITDA
163.20
Dividend Yield
0.21 %
Industry
Healthcare
Return on Equity
8.27
Debt to Equity
0.09
Forecast For
Actual

Company News

View All News
Caret
positive
Bliss GVS Pharma Limited has appointed Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah as Non-Executive Independent Directors for a 5-year term from April 03, 2026 to April 02, 2031.
neutral
Bliss GVS Pharma Limited submitted its quarterly certificate under SEBI Regulation 74(5) for Q4FY26 to NSE and BSE, confirming compliance with depositories regulations for securities dematerialisation.
neutral
Bliss GVS Pharma clarifies that media reports about potential stake acquisition by Anupam Rasayan are speculative and not based on official communication.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,694.60
#1 4,06,591.30
37.12
#1 54,729.00
9.71
#1 10,980
16.07
38.21
5,821.00
1,54,529.26
62.72
9,712.00
18.67
2,191
-1.02
31.76
4,011.60
1,35,770.77
59.42
11,539.40
6.99
1,911
26.24
34.97
2,279.90
1,04,201.28
22.29
22,909.50
13.74
3,306
#1 37.44
48.28
1,217.80
1,01,642.83
18.40
33,741.20
16.73
5,725
-15.28
39.48
1,200.90
97,006.38
21.27
28,409.50
7.12
5,291
-57.18
30.08
866.30
87,170.05
#1 17.30
23,511.00
18.55
4,615
-0.32
42.13
2,017.70
83,291.68
45.73
12,744.20
#1 20.90
2,007
7.65
43.82
1,340.40
77,850.65
22.27
32,345.60
9.43
3,484
7.59
65.39
5,236.50
62,610.21
25.95
13,458.30
3.70
2,216
1.90
41.60
Growth Rate
Revenue Growth
5.91 %
Net Income Growth
10.66 %
Cash Flow Change
3.01 %
ROE
1.72 %
ROCE
0.94 %
EBITDA Margin (Avg.)
-14.12 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
100
184
138
148
146
162
235
241
226
239
198
173
219
253
217
247
214
223
153
139
137
154
168
138
176
201
222
179
196
175
211
188
165
225
206
204
188
223
226
210
243
253
237
Expenses
60
132
104
95
101
126
187
182
161
179
148
164
165
187
177
212
163
185
115
117
110
120
126
115
134
167
256
147
150
148
158
179
135
158
157
199
149
176
181
177
166
201
186
EBITDA
40
51
34
52
46
36
48
60
65
61
50
9
55
66
40
35
51
38
39
21
27
35
42
23
42
35
-33
32
46
27
53
9
29
67
49
5
39
47
45
33
77
52
51
Operating Profit %
36 %
25 %
21 %
34 %
27 %
21 %
18 %
27 %
28 %
20 %
25 %
2 %
20 %
18 %
20 %
13 %
23 %
12 %
22 %
2 %
15 %
21 %
23 %
13 %
21 %
15 %
-18 %
12 %
21 %
14 %
23 %
3 %
15 %
26 %
22 %
-0 %
19 %
19 %
14 %
11 %
20 %
18 %
15 %
Depreciation
3
6
3
2
4
4
11
1
5
5
7
5
2
2
2
2
3
4
3
3
4
4
4
4
4
4
4
4
5
5
5
5
6
6
7
7
7
7
8
8
8
8
8
Interest
5
5
2
7
4
4
4
8
7
6
5
5
1
1
1
1
1
1
1
5
2
0
1
2
1
1
1
2
2
2
1
5
2
2
2
2
2
4
1
2
6
3
2
Profit Before Tax
33
41
31
43
41
36
38
60
56
52
39
-1
51
63
37
32
47
34
34
13
20
30
37
17
37
30
-39
27
39
20
47
-1
22
59
40
-4
30
36
36
23
63
41
41
Tax
13
13
7
15
13
15
17
18
19
12
13
12
12
21
9
13
14
3
9
8
4
8
10
8
11
8
10
3
12
4
18
-4
7
16
11
1
8
10
11
7
19
12
16
Net Profit
20
28
24
29
28
21
22
43
37
40
26
-14
39
42
27
19
33
31
26
6
17
22
28
8
26
22
-49
24
28
16
30
4
14
43
29
-5
22
26
26
17
44
29
25
EPS in ₹
1.89
2.23
2.15
1.71
2.67
2.46
2.02
3.21
2.05
4.93
1.74
-1.39
3.72
4.02
2.50
1.76
3.28
3.00
2.30
0.85
1.57
1.99
2.48
0.61
2.35
2.05
-4.83
1.90
2.48
1.33
2.68
0.34
1.41
4.06
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
2.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
662
762
1,023
860
905
1,027
1,077
1,109
1,157
1,212
1,301
Fixed Assets
234
225
305
143
146
242
234
282
379
370
406
Current Assets
417
471
566
690
694
770
765
777
697
811
827
Capital Work in Progress
0
9
4
1
47
0
2
22
3
8
21
Investments
0
0
0
0
0
0
0
2
8
4
4
Other Assets
428
527
714
717
712
786
840
803
768
830
870
Total Equity & Liabilities
662
762
1,023
860
905
1,027
1,077
1,109
1,157
1,212
1,301
Current Liabilities
243
267
437
299
207
231
204
233
193
157
172
Non Current Liabilities
68
50
33
13
38
46
45
29
46
51
37
Total Equity
352
446
553
548
660
750
828
847
917
1,003
1,092
Reserve & Surplus
327
402
476
526
636
725
798
808
874
957
1,040
Share Capital
10
10
10
10
10
10
10
10
10
11
11

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-34
23
30
-11
-22
0
-2
9
3
-1
0
Investing Activities
-30
-50
-249
48
-79
-40
-45
-103
-6
-83
-75
Operating Activities
38
113
290
18
40
47
64
136
34
103
106
Financing Activities
-42
-40
-10
-76
17
-6
-21
-24
-25
-21
-30

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
33.31 %
33.24 %
33.19 %
33.14 %
33.14 %
34.51 %
34.55 %
34.46 %
35.04 %
35.12 %
35.06 %
34.97 %
34.97 %
34.90 %
34.82 %
35.10 %
35.29 %
35.44 %
35.39 %
35.36 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
16.31 %
0.00 %
14.73 %
13.25 %
12.13 %
13.51 %
13.18 %
12.65 %
13.27 %
14.54 %
DIIs
6.72 %
6.72 %
6.67 %
6.66 %
6.66 %
6.65 %
6.64 %
6.63 %
6.63 %
6.62 %
6.61 %
6.59 %
6.59 %
6.58 %
6.57 %
6.55 %
6.55 %
6.54 %
5.98 %
5.78 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.45 %
26.90 %
27.59 %
28.26 %
30.37 %
30.15 %
30.57 %
30.74 %
30.00 %
30.10 %
29.17 %
30.78 %
31.71 %
32.84 %
34.57 %
32.93 %
32.63 %
32.79 %
32.85 %
31.48 %
Others
36.52 %
33.14 %
32.55 %
31.95 %
29.84 %
28.69 %
28.24 %
28.18 %
28.33 %
28.15 %
12.84 %
27.66 %
12.00 %
12.43 %
11.92 %
11.91 %
12.34 %
12.58 %
12.51 %
12.84 %
No of Share Holders
28,543
39,999
42,742
41,080
45,866
46,327
45,753
44,983
43,041
42,182
43,234
40,758
45,157
44,737
52,937
49,558
49,517
46,707
44,461
43,380

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.6 1 1 0.5 0.5 0.5 0.5 0.5 0.5 0.00
Dividend Yield (%) 0.31 0.56 0.99 0.51 0.65 0.71 0.44 0.42 0.23 0.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication3 hrs ago
Announcement under Regulation 30 (LODR)-Change in Directorate3 days ago
Outcome Of The Circular Resolution Passed By The Board Of Directors3 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20184 days ago
Closure of Trading Window6 days ago
Communication To The Shareholders Regarding Tax Deduction On Interim Dividend Declared On February 10 2026Feb 17, 2026
Rumour verification - Regulation 30(11)Feb 13, 2026
Clarification On News Item Appearing In CNBC ????? On February 13 2026Feb 13, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 10, 2026
Corporate Action-Board approves DividendFeb 10, 2026
Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019Feb 10, 2026
Details Of Kmps For Reporting Of Disclosure Of Material Events To Stock ExchangesFeb 10, 2026
Outcome Of Board Meeting Held On Tuesday February 10 2026Feb 10, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday February 10 2026Feb 10, 2026
Board Meeting Intimation for The Meeting Board Of Directors Of The Company Is Scheduled To Be Held On Tuesday February 10 2026.Feb 03, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 30, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 30, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 27, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 31, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 30, 2025
Closure of Trading WindowDec 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 23, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday December 23 2025Dec 23, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 09, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019Nov 06, 2025
Details Of Kmps For Reporting Of Disclosure Of Material Events To Stock ExchangesNov 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 06, 2025
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Yearly Ended September 30 2025Nov 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday November 06 2025Nov 06, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 05, 2025
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.Oct 29, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 10, 2025
Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 06, 2025
Closure of Trading WindowSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday September 30 2025Sep 30, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 15, 2025
Announcement under Regulation 30 (LODR)-Credit RatingSep 03, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 01, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.10%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
61.15
ATR(14)
Volatile
13.38
STOCH(9,6)
Neutral
72.76
STOCH RSI(14)
Overbought
86.95
MACD(12,26)
Bullish
1.68
ADX(14)
Weak Trend
16.73
UO(9)
Bearish
52.86
ROC(12)
Uptrend And Accelerating
15.17
WillR(14)
Overbought
-4.57